Format
Sort by
Items per page

Send to

Choose Destination

Best matches for breast cancer curcumin:

Search results

Items: 1 to 20 of 629

1.

Prevention of breast cancer by dietary polyphenols-role of cancer stem cells.

Gu HF, Mao XY, Du M.

Crit Rev Food Sci Nutr. 2019 Jan 11:1-16. doi: 10.1080/10408398.2018.1551778. [Epub ahead of print]

PMID:
30632783
2.

Anti-tumour effects of TRAIL-expressing human placental derived mesenchymal stem cells with curcumin-loaded chitosan nanoparticles in a mice model of triple negative breast cancer.

Kamalabadi-Farahani M, Vasei M, Ahmadbeigi N, Ebrahimi-Barough S, Soleimani M, Roozafzoon R.

Artif Cells Nanomed Biotechnol. 2018 Dec 24:1-11. doi: 10.1080/21691401.2018.1527345. [Epub ahead of print]

PMID:
30580635
3.

Folic acid conjugated curcumin loaded biopolymeric gum acacia microsphere for triple negative breast cancer therapy in invitro and invivo model.

Pal K, Roy S, Parida PK, Dutta A, Bardhan S, Das S, Jana K, Karmakar P.

Mater Sci Eng C Mater Biol Appl. 2019 Feb 1;95:204-216. doi: 10.1016/j.msec.2018.10.071. Epub 2018 Oct 22.

PMID:
30573243
4.

Role of curcumin in regulating p53 in breast cancer: an overview of the mechanism of action.

Talib WH, Al-Hadid SA, Ali MBW, Al-Yasari IH, Ali MRA.

Breast Cancer (Dove Med Press). 2018 Nov 29;10:207-217. doi: 10.2147/BCTT.S167812. eCollection 2018. Review.

5.

Synergic Activity Against MCF-7 Breast Cancer Cell Growth of Nanocurcumin-Encapsulated and Cisplatin-Complexed Nanogels.

Nguyen NT, Nguyen NNT, Tran NTN, Le PN, Nguyen TBT, Nguyen NH, Bach LG, Doan VN, Tran HLB, Le VT, Tran NQ.

Molecules. 2018 Dec 18;23(12). pii: E3347. doi: 10.3390/molecules23123347.

6.

Inhibition of breast cancer metastasis to the lungs with UBS109.

Shoji M, Qian WP, Nagaraju GP, Brat DJ, Pessolano D, Luzietti R, Chennamadhavuni S, Yamaguchi M, Yang L, Liotta DC.

Oncotarget. 2018 Nov 16;9(90):36102-36109. doi: 10.18632/oncotarget.26302. eCollection 2018 Nov 16.

7.

Curcumin-loaded nanoemulsion: a new safe and effective formulation to prevent tumor reincidence and metastasis.

Guerrero S, Inostroza-Riquelme M, Contreras-Orellana P, Diaz-Garcia V, Lara P, Vivanco-Palma A, Cárdenas A, Miranda V, Robert P, Leyton L, Kogan MJ, Quest AFG, Oyarzun-Ampuero F.

Nanoscale. 2018 Dec 21;10(47):22612-22622. doi: 10.1039/c8nr06173d. Epub 2018 Nov 28.

PMID:
30484463
8.

Molecular targets of curcumin in breast cancer (Review).

Song X, Zhang M, Dai E, Luo Y.

Mol Med Rep. 2018 Nov 19. doi: 10.3892/mmr.2018.9665. [Epub ahead of print]

PMID:
30483727
9.

Synergistic anticancer action of quercetin and curcumin against triple-negative breast cancer cell lines.

Kundur S, Prayag A, Selvakumar P, Nguyen H, McKee L, Cruz C, Srinivasan A, Shoyele S, Lakshmikuttyamma A.

J Cell Physiol. 2018 Nov 27. doi: 10.1002/jcp.27761. [Epub ahead of print]

PMID:
30478904
10.

Curcumin prevented human autocrine growth hormone (GH) signaling mediated NF-κB activation and miR-183-96-182 cluster stimulated epithelial mesenchymal transition in T47D breast cancer cells.

Coker-Gurkan A, Bulut D, Genc R, Arisan ED, Obakan-Yerlikaya P, Palavan-Unsal N.

Mol Biol Rep. 2018 Nov 23. doi: 10.1007/s11033-018-4479-y. [Epub ahead of print]

PMID:
30467667
11.

Diverse effects of different "protein-based" vehicles on the stability and bioavailability of curcumin: Spectroscopic evaluation of the antioxidant activity and cytotoxicity in vitro.

Khodarahmi R, Farideh M, Hosseinzadeh L, Ashrafi-Kooshk MR, Esmaeili S, Ghobadi S, Farzaei MH.

Protein Pept Lett. 2018 Nov 14. doi: 10.2174/0929866525666181114152242. [Epub ahead of print]

PMID:
30430934
12.

Magnetic Alginate/Chitosan Nanoparticles for Targeted Delivery of Curcumin into Human Breast Cancer Cells.

Song W, Su X, Gregory DA, Li W, Cai Z, Zhao X.

Nanomaterials (Basel). 2018 Nov 5;8(11). pii: E907. doi: 10.3390/nano8110907.

13.

Curcumin, but not curcumin-glucuronide, inhibits Smad signaling in TGFβ-dependent bone metastatic breast cancer cells and is enriched in bone compared to other tissues.

Kunihiro AG, Brickey JA, Frye JB, Luis PB, Schneider C, Funk JL.

J Nutr Biochem. 2019 Jan;63:150-156. doi: 10.1016/j.jnutbio.2018.09.021. Epub 2018 Oct 11.

PMID:
30393127
14.

Curcumin ameliorates PRMT5-MEP50 arginine methyltransferase expression by decreasing the Sp1 and NF-YA transcription factors in the A549 and MCF-7 cells.

Chatterjee B, Ghosh K, Suresh L, Kanade SR.

Mol Cell Biochem. 2018 Nov 3. doi: 10.1007/s11010-018-3471-0. [Epub ahead of print]

PMID:
30392062
15.

Curcumin⁻Copper Complex Nanoparticles for the Management of Triple-Negative Breast Cancer.

Greish K, Pittalà V, Taurin S, Taha S, Bahman F, Mathur A, Jasim A, Mohammed F, El-Deeb IM, Fredericks S, Rashid-Doubell F.

Nanomaterials (Basel). 2018 Nov 1;8(11). pii: E884. doi: 10.3390/nano8110884.

16.

Molecular Responses of Cancers by Natural Products: Modifications of Autophagy Revealed by Literature Analysis.

Yeung AWK, El-Demerdash A, Berindan-Neagoe I, Atanasov AG, Ho YS.

Crit Rev Oncog. 2018;23(5-6):347-370. doi: 10.1615/CritRevOncog.2018027566.

PMID:
30311565
17.

Photodynamic treatment with anionic nanoclays containing curcumin on human triple-negative breast cancer cells: Cellular and biochemical studies.

Khorsandi K, Hosseinzadeh R, Shahidi FK.

J Cell Biochem. 2018 Oct 9. doi: 10.1002/jcb.27775. [Epub ahead of print]

PMID:
30302810
18.

A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study.

Martínez N, Herrera M, Frías L, Provencio M, Pérez-Carrión R, Díaz V, Morse M, Crespo MC.

Clin Transl Oncol. 2018 Oct 6. doi: 10.1007/s12094-018-1950-0. [Epub ahead of print]

PMID:
30293230
19.

Chitosan/alginate nanoparticles as a promising approach for oral delivery of curcumin diglutaric acid for cancer treatment.

Sorasitthiyanukarn FN, Muangnoi C, Ratnatilaka Na Bhuket P, Rojsitthisak P, Rojsitthisak P.

Mater Sci Eng C Mater Biol Appl. 2018 Dec 1;93:178-190. doi: 10.1016/j.msec.2018.07.069. Epub 2018 Jul 25.

PMID:
30274050
20.

A mono-carbonyl analog of curcumin induces apoptosis in drug-resistant EGFR-mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunction.

Dai X, Zhang J, Guo G, Cai Y, Cui R, Yin C, Liu W, Vinothkumar R, Zhang T, Liang G, Zhang X.

Cancer Manag Res. 2018 Aug 29;10:3069-3082. doi: 10.2147/CMAR.S159660. eCollection 2018.

Supplemental Content

Loading ...
Support Center